Economic evaluation of pharmaceuticals: What are reasonable standards for clinical evidence - The Australian experience

Suzanne Hill^*, David Henry, Brita Pekarsky, Andrew Mitchell

^*Corresponding author for this work

Research output: Contribution to journal › Review article › Research › peer-review

9 Citations (Scopus)

Original language	English
Pages (from-to)	421-425
Number of pages	5
Journal	British Journal of Clinical Pharmacology
Volume	44
Issue number	5
DOIs	https://doi.org/10.1046/j.1365-2125.1997.t01-1-00597.x
Publication status	Published - 1997
Externally published	Yes

Access to Document

@article{42a7f4caf115491db7469d13e67adea4,

title = "Economic evaluation of pharmaceuticals: What are reasonable standards for clinical evidence - The Australian experience",

author = "Suzanne Hill and David Henry and Brita Pekarsky and Andrew Mitchell",

year = "1997",

doi = "10.1046/j.1365-2125.1997.t01-1-00597.x",

language = "English",

volume = "44",

pages = "421--425",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "BLACKWELL SCIENCE LTD",

number = "5",

}

TY - JOUR

T1 - Economic evaluation of pharmaceuticals: What are reasonable standards for clinical evidence - The Australian experience

AU - Hill, Suzanne

AU - Henry, David

AU - Pekarsky, Brita

AU - Mitchell, Andrew

PY - 1997

Y1 - 1997

UR - http://www.scopus.com/inward/record.url?scp=0030707474&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2125.1997.t01-1-00597.x

DO - 10.1046/j.1365-2125.1997.t01-1-00597.x

M3 - Review article

C2 - 9384457

AN - SCOPUS:0030707474

SN - 0306-5251

VL - 44

SP - 421

EP - 425

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

IS - 5

ER -